Eli Lilly and Company (LLY)
USD 764.71
(-1.79%)
USD 764.71
(-1.79%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 5.77 Billion USD | 33.95% |
| 2022 | 4.3 Billion USD | 10.9% |
| 2021 | 3.88 Billion USD | -2.37% |
| 2020 | 3.98 Billion USD | 24.75% |
| 2019 | 3.19 Billion USD | 2.99% |
| 2018 | 3.09 Billion USD | -30.51% |
| 2017 | 4.45 Billion USD | 25.17% |
| 2016 | 3.56 Billion USD | 3.37% |
| 2015 | 3.44 Billion USD | 25.76% |
| 2014 | 2.74 Billion USD | -6.45% |
| 2013 | 2.92 Billion USD | 10.78% |
| 2012 | 2.64 Billion USD | 14.96% |
| 2011 | 2.29 Billion USD | -8.65% |
| 2010 | 2.51 Billion USD | -11.66% |
| 2009 | 2.84 Billion USD | 14.31% |
| 2008 | 2.49 Billion USD | -1.21% |
| 2007 | 2.52 Billion USD | 11.16% |
| 2006 | 2.27 Billion USD | 20.89% |
| 2005 | 1.87 Billion USD | -18.05% |
| 2004 | 2.29 Billion USD | 16.74% |
| 2003 | 1.96 Billion USD | 31.27% |
| 2002 | 1.49 Billion USD | 41.05% |
| 2001 | 1.06 Billion USD | 20.05% |
| 2000 | 883.1 Million USD | -1.83% |
| 1999 | 899.6 Million USD | -10.03% |
| 1998 | 999.9 Million USD | 11.01% |
| 1997 | 900.7 Million USD | 2.19% |
| 1996 | 881.4 Million USD | 4.98% |
| 1995 | 839.6 Million USD | -13.35% |
| 1994 | 968.9 Million USD | -12.16% |
| 1993 | 1.1 Billion USD | 17.54% |
| 1992 | 938.4 Million USD | 17.76% |
| 1991 | 796.9 Million USD | 18.41% |
| 1990 | 673 Million USD | 12.26% |
| 1989 | 599.5 Million USD | -11.09% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 6.48 Billion USD | 6.22% |
| 2024 Q1 | 6.1 Billion USD | 5.7% |
| 2024 Q3 | 7.45 Billion USD | 15.09% |
| 2023 Q4 | 5.77 Billion USD | 17.78% |
| 2023 FY | 5.77 Billion USD | 33.95% |
| 2023 Q1 | 4.54 Billion USD | 5.46% |
| 2023 Q2 | 4.79 Billion USD | 5.59% |
| 2023 Q3 | 4.9 Billion USD | 2.14% |
| 2022 Q4 | 4.3 Billion USD | 12.49% |
| 2022 Q2 | 3.89 Billion USD | 0.16% |
| 2022 FY | 4.3 Billion USD | 10.9% |
| 2022 Q3 | 3.83 Billion USD | -1.75% |
| 2022 Q1 | 3.89 Billion USD | 0.18% |
| 2021 FY | 3.88 Billion USD | -2.37% |
| 2021 Q4 | 3.88 Billion USD | -0.55% |
| 2021 Q3 | 3.9 Billion USD | 2.16% |
| 2021 Q2 | 3.82 Billion USD | 4.48% |
| 2021 Q1 | 3.66 Billion USD | -8.03% |
| 2020 Q3 | 3.55 Billion USD | 7.29% |
| 2020 FY | 3.98 Billion USD | 24.75% |
| 2020 Q2 | 3.31 Billion USD | 6.82% |
| 2020 Q1 | 3.1 Billion USD | -2.77% |
| 2020 Q4 | 3.98 Billion USD | 11.95% |
| 2019 Q4 | 3.19 Billion USD | 2.88% |
| 2019 Q2 | 3.18 Billion USD | 4.12% |
| 2019 Q1 | 3.05 Billion USD | -1.38% |
| 2019 FY | 3.19 Billion USD | 2.99% |
| 2019 Q3 | 3.1 Billion USD | -2.51% |
| 2018 Q2 | 4.15 Billion USD | -10.27% |
| 2018 Q3 | 4.11 Billion USD | -0.9% |
| 2018 FY | 3.09 Billion USD | -30.51% |
| 2018 Q1 | 4.63 Billion USD | 3.88% |
| 2018 Q4 | 3.09 Billion USD | -24.77% |
| 2017 Q3 | 4.4 Billion USD | 1.4% |
| 2017 Q1 | 4.03 Billion USD | 13.29% |
| 2017 Q4 | 4.45 Billion USD | 1.17% |
| 2017 FY | 4.45 Billion USD | 25.17% |
| 2017 Q2 | 4.34 Billion USD | 7.7% |
| 2016 Q1 | 3.74 Billion USD | 8.54% |
| 2016 FY | 3.56 Billion USD | 3.37% |
| 2016 Q3 | 3.88 Billion USD | 3.23% |
| 2016 Q4 | 3.56 Billion USD | -8.23% |
| 2016 Q2 | 3.75 Billion USD | 0.53% |
| 2015 Q3 | 3.41 Billion USD | 3.93% |
| 2015 Q1 | 2.98 Billion USD | 8.77% |
| 2015 FY | 3.44 Billion USD | 25.76% |
| 2015 Q4 | 3.44 Billion USD | 0.82% |
| 2015 Q2 | 3.28 Billion USD | 10.34% |
| 2014 Q3 | 2.84 Billion USD | -10.84% |
| 2014 FY | 2.74 Billion USD | -6.45% |
| 2014 Q1 | 2.96 Billion USD | 1.37% |
| 2014 Q2 | 3.19 Billion USD | 7.45% |
| 2014 Q4 | 2.74 Billion USD | -3.67% |
| 2013 Q2 | 2.72 Billion USD | 5.77% |
| 2013 Q4 | 2.92 Billion USD | -1.52% |
| 2013 FY | 2.92 Billion USD | 10.78% |
| 2013 Q1 | 2.57 Billion USD | -2.54% |
| 2013 Q3 | 2.97 Billion USD | 9.13% |
| 2012 Q2 | 2.32 Billion USD | -4.27% |
| 2012 Q3 | 2.55 Billion USD | 10.02% |
| 2012 Q4 | 2.64 Billion USD | 3.54% |
| 2012 FY | 2.64 Billion USD | 14.96% |
| 2012 Q1 | 2.42 Billion USD | 5.41% |
| 2011 Q2 | 2.87 Billion USD | 3.72% |
| 2011 Q3 | 2.51 Billion USD | -12.43% |
| 2011 Q4 | 2.29 Billion USD | -8.49% |
| 2011 FY | 2.29 Billion USD | -8.65% |
| 2011 Q1 | 2.76 Billion USD | 9.91% |
| 2010 Q1 | 2.47 Billion USD | -13.29% |
| 2010 FY | 2.51 Billion USD | -11.66% |
| 2010 Q2 | 2.17 Billion USD | -12.01% |
| 2010 Q3 | 2.68 Billion USD | 23.25% |
| 2010 Q4 | 2.51 Billion USD | -6.06% |
| 2009 FY | 2.84 Billion USD | 14.31% |
| 2009 Q4 | 2.84 Billion USD | -8.9% |
| 2009 Q3 | 3.12 Billion USD | 4.28% |
| 2009 Q2 | 2.99 Billion USD | 17.68% |
| 2009 Q1 | 2.54 Billion USD | 2.24% |
| 2008 Q3 | 2.11 Billion USD | -17.08% |
| 2008 Q4 | 2.49 Billion USD | 18.07% |
| 2008 FY | 2.49 Billion USD | -1.21% |
| 2008 Q1 | 2.59 Billion USD | 2.8% |
| 2008 Q2 | 2.54 Billion USD | -1.85% |
| 2007 Q2 | 2.33 Billion USD | 2.29% |
| 2007 Q1 | 2.27 Billion USD | 0.33% |
| 2007 Q4 | 2.52 Billion USD | 1.03% |
| 2007 FY | 2.52 Billion USD | 11.16% |
| 2007 Q3 | 2.49 Billion USD | 7.21% |
| 2006 FY | 2.27 Billion USD | 20.89% |
| 2006 Q4 | 2.27 Billion USD | 3.2% |
| 2006 Q3 | 2.19 Billion USD | 4.79% |
| 2006 Q2 | 2.09 Billion USD | 6.61% |
| 2006 Q1 | 1.96 Billion USD | 4.85% |
| 2005 Q4 | 1.87 Billion USD | -3.69% |
| 2005 Q3 | 1.94 Billion USD | -1.96% |
| 2005 Q2 | 1.98 Billion USD | -9.53% |
| 2005 Q1 | 2.19 Billion USD | -4.07% |
| 2005 FY | 1.87 Billion USD | -18.05% |
| 2004 Q3 | 2.09 Billion USD | 1.61% |
| 2004 Q1 | 2.03 Billion USD | 3.9% |
| 2004 Q2 | 2.05 Billion USD | 0.95% |
| 2004 Q4 | 2.29 Billion USD | 9.54% |
| 2004 FY | 2.29 Billion USD | 16.74% |
| 2003 Q4 | 1.96 Billion USD | 15.49% |
| 2003 FY | 1.96 Billion USD | 31.27% |
| 2003 Q1 | 1.58 Billion USD | 5.97% |
| 2003 Q2 | 1.7 Billion USD | 7.9% |
| 2003 Q3 | 1.69 Billion USD | -0.6% |
| 2002 Q2 | 1.35 Billion USD | 23.83% |
| 2002 Q4 | 1.49 Billion USD | 8.49% |
| 2002 Q1 | 1.09 Billion USD | 3.49% |
| 2002 FY | 1.49 Billion USD | 41.05% |
| 2002 Q3 | 1.37 Billion USD | 1.45% |
| 2001 Q4 | 1.06 Billion USD | 0.78% |
| 2001 FY | 1.06 Billion USD | 20.05% |
| 2001 Q3 | 1.05 Billion USD | 9.95% |
| 2001 Q2 | 956.8 Million USD | 8.32% |
| 2001 Q1 | 883.3 Million USD | 0.02% |
| 2000 FY | 883.1 Million USD | -1.83% |
| 2000 Q1 | 899.6 Million USD | 0.0% |
| 2000 Q2 | 935.8 Million USD | 4.02% |
| 2000 Q3 | 905 Million USD | -3.29% |
| 2000 Q4 | 883.1 Million USD | -2.42% |
| 1999 Q4 | 899.6 Million USD | -12.6% |
| 1999 Q3 | 1.02 Billion USD | 9.11% |
| 1999 Q2 | 943.4 Million USD | 1.46% |
| 1999 Q1 | 929.8 Million USD | -7.01% |
| 1999 FY | 899.6 Million USD | -10.03% |
| 1998 Q1 | 977.8 Million USD | 8.56% |
| 1998 FY | 999.9 Million USD | 11.01% |
| 1998 Q4 | 999.9 Million USD | -2.78% |
| 1998 Q3 | 1.02 Billion USD | 4.4% |
| 1998 Q2 | 985.2 Million USD | 0.76% |
| 1997 Q3 | 914.7 Million USD | -3.29% |
| 1997 Q1 | 876.3 Million USD | -0.58% |
| 1997 Q2 | 945.8 Million USD | 7.93% |
| 1997 FY | 900.7 Million USD | 2.19% |
| 1997 Q4 | 900.7 Million USD | -1.53% |
| 1996 Q1 | 843.7 Million USD | 0.49% |
| 1996 Q3 | 878.3 Million USD | 0.91% |
| 1996 Q4 | 881.4 Million USD | 0.35% |
| 1996 FY | 881.4 Million USD | 4.98% |
| 1996 Q2 | 870.4 Million USD | 3.16% |
| 1995 Q4 | 839.6 Million USD | 0.67% |
| 1995 Q1 | 901.1 Million USD | -7.0% |
| 1995 FY | 839.6 Million USD | -13.35% |
| 1995 Q2 | 903.4 Million USD | 0.26% |
| 1995 Q3 | 834 Million USD | -7.68% |
| 1994 Q3 | 1.04 Billion USD | -7.9% |
| 1994 Q4 | 968.9 Million USD | -7.01% |
| 1994 Q1 | 1.09 Billion USD | -0.71% |
| 1994 FY | 968.9 Million USD | -12.16% |
| 1994 Q2 | 1.13 Billion USD | 3.3% |
| 1993 Q2 | 1.06 Billion USD | 4.25% |
| 1993 Q3 | 1.14 Billion USD | 8.11% |
| 1993 Q4 | 1.1 Billion USD | -3.85% |
| 1993 FY | 1.1 Billion USD | 17.54% |
| 1993 Q1 | 1.01 Billion USD | 8.46% |
| 1992 FY | 938.4 Million USD | 17.76% |
| 1992 Q1 | 806.2 Million USD | 1.17% |
| 1992 Q2 | 897.7 Million USD | 11.35% |
| 1992 Q3 | 893.4 Million USD | -0.48% |
| 1992 Q4 | 938.4 Million USD | 5.04% |
| 1991 Q2 | 733.4 Million USD | 4.22% |
| 1991 Q4 | 796.9 Million USD | 0.49% |
| 1991 Q3 | 793 Million USD | 8.13% |
| 1991 Q1 | 703.7 Million USD | 4.56% |
| 1991 FY | 796.9 Million USD | 18.41% |
| 1990 Q2 | 624.7 Million USD | 3.75% |
| 1990 Q3 | 675.3 Million USD | 8.1% |
| 1990 Q4 | 673 Million USD | -0.34% |
| 1990 FY | 673 Million USD | 12.26% |
| 1990 Q1 | 602.1 Million USD | 0.43% |
| 1989 Q3 | 667 Million USD | 6.7% |
| 1989 FY | 599.5 Million USD | -11.09% |
| 1989 Q4 | 599.5 Million USD | -10.12% |
| 1989 Q2 | 625.1 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AbbVie Inc. | 4.09 Billion USD | -40.834% |
| Bristol-Myers Squibb Company | 2.66 Billion USD | -116.86% |
| Bristol-Myers Squibb Company Ce | 2.66 Billion USD | -116.86% |
| Johnson & Johnson | 11.18 Billion USD | 48.37% |
| Merck & Co., Inc. | 6.35 Billion USD | 9.204% |
| Novartis AG | 5.91 Billion USD | 2.371% |
| Organon & Co. | 1.31 Billion USD | -338.996% |
| Pfizer Inc. | 10.18 Billion USD | 43.343% |